Statins: Promising Protective Shield against Doxorubicin Cardiotoxicity

Ali Shalizar Jalali
Additional contact information
Ali Shalizar Jalali: Department of Basic Sciences, Urmia University, Iran

Journal of Cardiology & Cardiovascular Therapy, 2017, vol. 7, issue 2, 58-59

Abstract: Doxorubicin (DOX) as a 40 year-old anthracycline antibiotic is a potent antineoplastic agent extensively used in the treatment of several malignancies.

Keywords: cardiology journal; scholarly articles on cardiology; cardiology citation report; cardiology citations; cardiology medical journals; free cardiology medical journals; cardiology journals; Cardiovascular Therapy; juniper publishers; juniper publishers open access journals (search for similar items in EconPapers)
Date: 2017
References: Add references at CitEc
Citations:

Downloads: (external link)
https://juniperpublishers.com/jocct/pdf/JOCCT.MS.ID.555710.pdf (application/pdf)
https://juniperpublishers.com/jocct/JOCCT.MS.ID.555710.php (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:adp:ojocct:v:7:y:2017:i:2:p:58-59

DOI: 10.19080/JOCCT.2017.07.555710

Access Statistics for this article

Journal of Cardiology & Cardiovascular Therapy is currently edited by Sophia Mathis

More articles in Journal of Cardiology & Cardiovascular Therapy from Juniper Publishers Inc.
Bibliographic data for series maintained by Robert Thomas ().